Sigma Planning Corp’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,527
Closed -$45.7K 1331
2023
Q1
$45.7K Buy
+2,527
New +$43.5K ﹤0.01% 1267
2022
Q2
Sell
-130
Closed -$7K 1410
2022
Q1
$7K Buy
130
+32
+33% +$1.36K ﹤0.01% 1359
2021
Q4
$4K Sell
98
-53
-35% -$2.84K ﹤0.01% 1383
2021
Q3
$10K Hold
151
﹤0.01% 1371
2021
Q2
$15K Hold
151
﹤0.01% 1412
2021
Q1
$19K Buy
151
+53
+54% +$7.83K ﹤0.01% 1324
2020
Q4
$11K Buy
98
+6
+7% +$672 ﹤0.01% 1190
2020
Q3
$11K Sell
92
-35
-28% -$6.06K ﹤0.01% 1058
2020
Q2
$27K Buy
127
+14
+12% +$3.31K ﹤0.01% 1038
2020
Q1
$26K Buy
+113
New +$32.2K ﹤0.01% 895
2016
Q1
Sell
-119
Closed -$134K 756
2015
Q4
$134K Buy
+119
New +$138K 0.02% 634
2015
Q3
Sell
-146
Closed -$260K 738
2015
Q2
$260K Buy
146
+1
+0.7% +$1.27K 0.04% 531
2015
Q1
$174K Buy
145
+15
+12% +$17.6K 0.02% 683
2014
Q4
$147K Buy
+130
New +$133K 0.02% 661

Other funds holding RMTI

Sigma Planning Corp's RMTI Position: Q2 2023 in Review

Sigma Planning Corp sold out of Rockwell Medical (RMTI) in Q2 2023, closing a stake of 2,527 shares — an estimated $45.7K sold.

Sigma Planning Corp first reported a position in RMTI in Q4 2014 and held it in 14 quarters. The position peaked at $260K in Q2 2015. 40 funds tracked by Wall St. Rank hold RMTI as of Q2 2023.

  • Sigma Planning Corp reported no remaining Rockwell Medical position as of Q2 2023 after selling out during the quarter.
  • Sigma Planning Corp sold 2,527 Rockwell Medical shares in Q2 2023, an estimated $45.7K.
  • Sigma Planning Corp first reported a position in Rockwell Medical in Q4 2014 and held it in 14 quarters.
  • Sigma Planning Corp's Rockwell Medical position peaked at $260K in Q2 2015.
  • 40 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2023.

Based on Sigma Planning Corp's 13F filing for Q2 2023, filed 2 Aug 2023.